Hoshi Iryo-Sanki (7634) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
7 Aug, 2026Executive summary
Revenue for Q1 FY2027 was ¥3,772 million, up 1.0% year-over-year; operating profit rose 7.6% to ¥409 million; ordinary profit increased 8.2% to ¥428 million; net income attributable to shareholders was ¥288 million, up 6.9%.
The company prioritized stable supply of products/services and safety for clients and employees, maintaining its social responsibility in the medical, nursing, and welfare sectors.
Financial highlights
Gross profit for Q1 FY2027 was ¥1,909 million, up from ¥1,889 million year-over-year.
Comprehensive income for Q1 FY2027 was ¥256 million, down 45.8% year-over-year.
EPS for Q1 FY2027 was ¥92.37, compared to ¥86.42 in the prior year.
Dividend forecast for FY2027 remains unchanged at ¥90 per share (¥45 interim, ¥45 year-end).
Outlook and guidance
Full-year FY2027 guidance: revenue ¥15,660 million (+0.9%), operating profit ¥1,980 million (+3.2%), ordinary profit ¥2,060 million (+3.0%), net income ¥1,400 million (+2.0%), EPS ¥448.31.
No changes to previously announced forecasts.
Latest events from Hoshi Iryo-Sanki
- Revenue rose 7.7% but profits fell over 20% year-over-year; guidance unchanged.7634
Q1 2025 - Modest profit growth and stable outlook, with a completed subsidiary merger for efficiency.7634
Q2 2025 - Revenue up 3.1% year-over-year, but profits dipped; outlook and dividend unchanged.7634
Q3 2025 - Modest profit growth driven by home healthcare and medical gas, with stable outlook ahead.7634
Q4 2025 - Revenue up 1.2% year-over-year, operating profit down 1.9%, dividend forecast raised.7634
Q2 2026 - Q1 FY2026 delivered strong profit growth and margin expansion, led by medical gas and home healthcare.7634
Q1 2026 - Revenue up 3.2% year-over-year, but profit margins pressured by rising costs.7634
Q3 2026 - Revenue up, profits down; home healthcare strong, outlook modestly positive.7634
Q4 2026